α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Por um escritor misterioso

Last updated 29 setembro 2024

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Labetalol is one of the most used drugs for the treatment of hypertension. This molecule is able to bind to both alpha-1 (α1) and beta (β) adrenergic …

Updates in the function and regulation of α1‐adrenoceptors - Akinaga - 2019 - British Journal of Pharmacology - Wiley Online Library

Drugs and Toxins - ScienceDirect

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes

Targeting of G-protein coupled receptors in sepsis - ScienceDirect

Drugs and Toxins - ScienceDirect

IJMS, Free Full-Text

In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane - ScienceDirect

Labetalol - an overview

IJTM, Free Full-Text

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

Role of adrenergic receptors in human coronary vasomotion

PDF) In vitro effects of the antitumor drug miltefosine on human erythrocytes and molecular models of its membrane

NATIONAL GUIDELINES ON QUALITY OBSTETRICS AND PERINATAL CARE Final Feb 2022 PDF, PDF, Malnutrition

Erythrocytes as model cells for biocompatibility assessment, cytotoxicity screening of xenobiotics and drug delivery - ScienceDirect

α1-and β-adrenergic antagonist labetalol induces morphological changes in human erythrocytes - ScienceDirect

Recomendado para você